Advanced search
Publication Cover
Acta Orthopaedica Volume 88, 2017 - Issue 1
Journal homepage
1,455
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Thromboembolic and major bleeding events in relation to perioperative bridging of vitamin K antagonists in 649 fast-track total hip and knee arthroplasties

Christoffer C JørgensenSection for Surgical Pathophysiology and; ;the Lundbeck Foundation Center for Fast-track Hip and Knee Replacement, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.Correspondence[email protected]
,
Henrik KehletSection for Surgical Pathophysiology and; ;the Lundbeck Foundation Center for Fast-track Hip and Knee Replacement, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
& on behalf of the Lundbeck Foundation Center for Fast-Track Hip and Knee Replacement Collaborative Group
Pages 55-61 | Received 20 May 2016, Accepted 16 Aug 2016, Published online: 19 Oct 2016

  • Andersen T F, Madsen M, Jorgensen J, Mellemkjoer L, Olsen J H. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46(3): 263–8.
  • Austin P C. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009; 28(25): 3083–107.
  • Ayoub K, Nairooz R, Almomani A, Marji M, Paydak H, Maskoun W. Perioperative heparin bridging in atrial fibrillation patients requiring temporary interruption of anticoagulation: evidence from meta-analysis. J Stroke Cerebrovasc Dis 2016; 25(9): 2215–21.
  • Breen D T, Chavalertsakul N, Paul E, Gruen R L, Serpell J. Perioperative complications in patients on low-molecular-weight heparin bridging therapy. ANZ J Surg 2016; 86(3): 167–72.
  • Clark N P, Witt D M, Davies L E, Saito E M, McCool K H, Douketis J D, Metz K R, Delate T. Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures. JAMA Intern Med 2015; 175(7): 1163–1168.
  • Daniels P R. Peri-procedural management of patients taking oral anticoagulants. BMJ 2015; 351: h2391.
  • Douketis J D. Contra: "Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery". Thromb Haemost 2012; 108(2): 210–212.
  • Douketis J D, Spyropoulos A C, Spencer F A, Mayr M, Jaffer A K, Eckman M H, Dunn A S, Kunz R. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e326S–e350S.
  • Douketis J D, Healey J S, Brueckmann M, Eikelboom J W, Ezekowitz M D, Fraessdorf M, Noack H, Oldgren J, Reilly P, Spyropoulos A C, Wallentin L, Connolly S J. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost 2015a; 113(3): 625–32.
  • Douketis J D, Spyropoulos A C, Kaatz S, Becker R C, Caprini J A, Dunn A S, Garcia D A, Jacobson A, Jaffer A K, Kong D F, Schulman S, Turpie A G, Hasselblad V, Ortel T L. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med 2015b; 373(9): 823–33.
  • Dunn A S, Spyropoulos A C, Turpie A G. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 2007; 5(11): 2211–2218.
  • Falck-Ytter Y, Francis C W, Johanson N A, Curley C, Dahl O E, Schulman S, Ortel T L, Pauker S G, Colwell C W, Jr. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e278S–e325S.
  • Gage B F, Waterman A D, Shannon W, Boechler M, Rich M W, Radford M J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285(22): 2864–70.
  • Haighton M, Kempen D H, Wolterbeek N, Marting L N, van D M, Veen R M. Bridging therapy for oral anticoagulation increases the risk for bleeding-related complications in total joint arthroplasty. J Orthop Surg Res 2015; 10: 145.
  • Husted H, Otte K S, Kristensen B B, Orsnes T, Wong C, Kehlet H. Low risk of thromboembolic complications after fast-track hip and knee arthroplasty. Acta Orthop 2010a; 81(5): 599–605.
  • Husted H, Solgaard S, Hansen T B, Soballe K, Kehlet H. Care principles at four fast-track arthroplasty departments in Denmark. Dan Med Bull 2010b; 57(7): A4166.
  • Johannesdottir SA, Horváth-Puhó E, Schmidt M, Ehrenstein V, Pedersen L, Sørensen HT. Existing data sources for clinical epidemiology:The Danish National Database of Reimbursed Prescriptions. Clin Epidemiol 2012; 4(4): 1–11.
  • Jorgensen C C, Kehlet H. Role of patient characteristics for fast-track hip and knee arthroplasty. Br J Anaesth 2013; 110(6): 972–80.
  • Jorgensen C C, Kehlet H. Early thromboembolic events < =1week after fast-track total hip and knee arthroplasty. Thromb Res 2016; 138: 37–42.
  • Jorgensen C C, Jacobsen M K, Soeballe K, Hansen T B, Husted H, Kjaersgaard-Andersen P, Hansen L T, Laursen M B, Kehlet H. Thromboprophylaxis only during hospitalisation in fast-track hip and knee arthroplasty, a prospective cohort study. BMJ Open 2013; 3(12): e003965.
  • Kehlet H. Fast-track hip and knee arthroplasty. Lancet 2013; 381(9878): 1600–2.
  • Khan S K, Malviya A, Muller S D, Carluke I, Partington P F, Emmerson K P, Reed M R. Reduced short-term complications and mortality following Enhanced Recovery primary hip and knee arthroplasty: results from 6,000 consecutive procedures. Acta Orthop 2014; 85(1): 26–31.
  • Kristensen S D, Knuuti J, Saraste A, Anker S, Botker H E, Hert S D, Ford I, Gonzalez-Juanatey J R, Gorenek B, Heyndrickx G R, Hoeft A, Huber K, Iung B, Kjeldsen K P, Longrois D, Luscher T F, Pierard L, Pocock S, Price S, Roffi M, Sirnes P A, Sousa-Uva M, Voudris V, Funck-Brentano C. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014; 35(35): 2383–431.
  • Leijtens B, Kremers v d H, Jansen J, Koeter S. High complication rate after total knee and hip replacement due to perioperative bridging of anticoagulant therapy based on the 2012 ACCP guideline. Arch Orthop Trauma Surg 2014; 134(9): 1335–41.
  • Lip G Y, Nieuwlaat R, Pisters R, Lane D A, Crijns H J. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137(2): 263–72.
  • McDougall C J, Gray H S, Simpson P M, Whitehouse S L, Crawford R W, Donnelly W J. Complications related to therapeutic anticoagulation in total hip arthroplasty. J Arthroplasty 2013; 28(1): 187–92.
  • Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La R L, De M, V, Testa S, Frontoni R, Prisco D, Nante G, Iliceto S. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation 2009; 119(22): 2920–7.
  • Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen M R, Fisher W. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 2010; 8(1): 202–4.
  • Severinsen M T, Kristensen S R, Overvad K, Dethlefsen C, Tjonneland A, Johnsen S P. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol 2010; 63(2): 223–8.
  • Siegal D, Yudin J, Kaatz S, Douketis J D, Lim W, Spyropoulos A C. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 2012; 126(13): 1630–9.
  • Spyropoulos A C. Pro: "Bridging anticoagulation is needed during warfarin interruption in patients who require elective surgery". Thromb Haemost 2012; 108(2): 213–6.
  • Spyropoulos A C, Douketis J D, Gerotziafas G, Kaatz S, Ortel T L, Schulman S. Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. J Thromb Haemost 2012; 10(4): 692–4.
  • The Danish Hip Arthroplasty Registry. Danish Hip Arthroplasty Registry, annual report 2013. http://www dhr dk/Ny%20mappe/rapporter/DHR%20årsrapport%202013_full%20versionfinal_ pdf [serial online] 2013; [cited 2013 Nov. 13].
  • The Danish Knee Registry. Annual Report 2013. https://www knee dk/groups/dkr/pdf/DKR_2013 pdf [serial online] 2015; [cited 2015 Sept. 15].
  • Thoemmes F. Propensity score matching in SPSS. http://sourceforge net/projects/psmspss/files/[serial online] 2012; [cited 2015 Sept. 15]. Available from .
  • van Walraven C, Bennett C, Forster A J. Administrative database research infrequently used validated diagnostic or procedural codes. J Clin Epidemiol 2011; 64(10): 1054–9.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.